Actively Recruiting
Comparative Study of the Quality of Life of Patients Suffering From OTOTOXICITY Due to Chemotherapy Based on Platinum Salts Fitted With a Hearing Aid Compared to Those Not Fitted.
Led by Institut de Cancérologie de Lorraine · Updated on 2025-11-28
52
Participants Needed
1
Research Sites
234 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
There are many undesirable effects associated with platinum-based cancer treatments (renal failure, anaemia, etc.). Their administration also leads to neurosensory problems such as ototoxicity, tinnitus and reduced hearing acuity. According to a the French survey (2018), 39.7% of people suffer from hearing problems due to cancer treatments, five years after a cancer diagnosis. Improving side effects such as hypoacusis and tinnitus can significantly improve patients' quality of life and adherence to treatment. Many clinical trials proposed a medicinal solution to patients receiving platinum-based cancer treatments but none has led to a consensus on management. The aim of the study is to offer patients receiving platinum-based chemotherapy and suffering from hearing problems a hearing aid to improve their quality of life.
CONDITIONS
Official Title
Comparative Study of the Quality of Life of Patients Suffering From OTOTOXICITY Due to Chemotherapy Based on Platinum Salts Fitted With a Hearing Aid Compared to Those Not Fitted.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult patient
- Currently receiving platinum-based chemotherapy
- Hearing loss consistent with chemotherapy confirmed by audiometric test
- Able and willing to follow study procedures
- Signed informed consent
- Affiliated to social security system
You will not qualify if you...
- Pregnant or breastfeeding women
- Persons deprived of liberty or under guardianship
- Unable to undergo medical monitoring due to geographical, social, or psychological reasons
- Contraindication to wearing hearing aids
- Already fitted with hearing aids
- Participating in another trial with an experimental drug
- Not yet started platinum-based chemotherapy
- Presence of tinnitus without hearing loss
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Institut de Cancerologie de Lorraine
Vandœuvre-lès-Nancy, France, 54500
Actively Recruiting
Research Team
J
JEAN LOUIS MERLIN, PUPH
CONTACT
C
CECILE HUIN SCHOHN, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here